cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.pza4dr
title: Occurrence Download

description: A dataset containing 10 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Distichodus engycephalus)",
 "BasisOfRecord is one of (Specimen, Literature Occurrence, Human Observation, Observation)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "Year is greater than or equal to 1991",
 "Year is less than or equal to 2025"
 ]
}

 The dataset includes 10 records from 8 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010039-250914085247600/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.ff7etd
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Leopecten stillmani",
 "HasCoordinate is true",
 "BasisOfRecord is one of (Observation, Machine Observation, Human Observation, Occurrence evidence)",
 {
 "not" : {
 "OccurrenceStatus" : [
 "is one of (Absent)"
 ]
 }
 }
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010045-250914085247600/datasets/export for details.
DOI: 10.17632/jc2zrktwv6
title: Raw Mapping data

description: Raw data acquired with a Bruker IRIS hyperspectral scanner.
Spectral reflectance data between 400 and 2500 nm.
X-ray fluorescence data.
DOI: 10.17632/jc2zrktwv6.1
title: Raw Mapping data

description: Raw data acquired with a Bruker IRIS hyperspectral scanner.
Spectral reflectance data between 400 and 2500 nm.
X-ray fluorescence data.
DOI: 10.15468/dl.adsanf
title: Occurrence Download

description: A dataset containing 20335 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Capreolus capreolus",
 "Country is Austria"
 ]
}

 The dataset includes 20335 records from 31 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010046-250914085247600/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.2909/2c559f1f-2df0-49cf-ba92-a04dd3ed02f4
title: Imperviousness Density Change 2018-2021 (raster 100 m), Europe, 3-yearly, Jun 2025

description: The Imperviousness Density Change (IMDC) 2018-2021 layer is part of the High Resolution Layer (HRL) Imperviousness. It contains the imperviousness change per pixel (increase or decrease in percentage) as derived from the difference between the Imperviousness Density (IMD) status layers for the reference years 2018 and 2021, in an aggregated version of 100m spatial resolution. The production of the HRL Imperviousness is coordinated by EEA in the frame of Copernicus, the Earth observation component of the European Union’s Space programme.

The product is a raster dataset with 100-meter grid spacing (spatial resolution) that covers the 38 Eionet member and cooperating countries as well as the United Kingdom (i.e. EEA38+UK). It is distributed as 100 x 100 km tiles that are fully conformant with the EEA reference grid.
DOI: 10.15468/dl.ahrhvg
title: Occurrence Download

description: A dataset containing 16 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Tanacetum balsamita",
 "Country is Canada",
 "HasCoordinate is true"
 ]
}

 The dataset includes 16 records from 10 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010048-250914085247600/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.jpwn5d
title: Occurrence Download

description: A dataset containing 27 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Tanacetum balsamita",
 "Country is Croatia",
 "HasCoordinate is true"
 ]
}

 The dataset includes 27 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010049-250914085247600/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.30145891
title: Supplementary Material for: Physical Activity and Stroke Incidence Among Post-Menopausal Women: Insights from the Women’s Health Initiative

description: Introduction: Stroke is a leading cause of morbidity and mortality, particularly in older adults. Identifying lifestyle factors, such as physical activity (PA), that mitigate stroke risk is critical for stroke prevention, especially in postmenopausal women. We sought to determine the association between levels and types of recreational PA and risk of total, ischemic, and hemorrhagic stroke in postmenopausal women.
Methods: We performed a prospective cohort study conducted within the Women’s Health Initiative from 1993 to 1998 with a mean follow up of 8.5 years. We studied a total of 139,871 postmenopausal women aged 50-79 years without prior cardiovascular disease or stroke at enrollment. Cox regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI). Recreational PA assessed via questionnaire, including total, light, moderate, and vigorous activities and walking. Incident total, ischemic, and hemorrhagic stroke. HRs and 95% CIs were adjusted for sociodemographic, lifestyle, and clinical factors. 
Results: During follow up, 4,642 stroke occurred (3,496 ischemic and 728 hemorrhagic). Higher levels of total PA (per 1-SD MET-hr/wk: HR=0.90, 95% CI: 0.87-0.93), walking (HR=0.93, 95% CI: 0.90-0.96), and moderate PA (HR=0.91, 95% CI: 0.88-0.94) were associated with reduced total stroke risk. Similar inverse associations were found for ischemic stroke. Vigorous PA demonstrated a J-shaped association with ischemic stroke, while light PA was not significantly associated with stroke risk. Total (HR=0.90, 95% CI: 0.83-0.97) and vigorous PA (HR=0.88, 95% CI: 0.81-0.96) were inversely associated with hemorrhagic stroke. Associations were consistent across subgroups defined by age, race/ethnicity, blood pressure, hormone therapy use, BMI, and dietary intake. 
Conclusion: Increased recreational PA, particularly moderate, with cautious interpretation of vigorous activity due to its J-shaped association and potential risks, is associated with reduced risks of total and ischemic stroke in postmenopausal women. Our findings support promoting PA as a key strategy for stroke prevention in this population.
DOI: 10.6084/m9.figshare.30145891.v1
title: Supplementary Material for: Physical Activity and Stroke Incidence Among Post-Menopausal Women: Insights from the Women’s Health Initiative

description: Introduction: Stroke is a leading cause of morbidity and mortality, particularly in older adults. Identifying lifestyle factors, such as physical activity (PA), that mitigate stroke risk is critical for stroke prevention, especially in postmenopausal women. We sought to determine the association between levels and types of recreational PA and risk of total, ischemic, and hemorrhagic stroke in postmenopausal women.
Methods: We performed a prospective cohort study conducted within the Women’s Health Initiative from 1993 to 1998 with a mean follow up of 8.5 years. We studied a total of 139,871 postmenopausal women aged 50-79 years without prior cardiovascular disease or stroke at enrollment. Cox regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI). Recreational PA assessed via questionnaire, including total, light, moderate, and vigorous activities and walking. Incident total, ischemic, and hemorrhagic stroke. HRs and 95% CIs were adjusted for sociodemographic, lifestyle, and clinical factors. 
Results: During follow up, 4,642 stroke occurred (3,496 ischemic and 728 hemorrhagic). Higher levels of total PA (per 1-SD MET-hr/wk: HR=0.90, 95% CI: 0.87-0.93), walking (HR=0.93, 95% CI: 0.90-0.96), and moderate PA (HR=0.91, 95% CI: 0.88-0.94) were associated with reduced total stroke risk. Similar inverse associations were found for ischemic stroke. Vigorous PA demonstrated a J-shaped association with ischemic stroke, while light PA was not significantly associated with stroke risk. Total (HR=0.90, 95% CI: 0.83-0.97) and vigorous PA (HR=0.88, 95% CI: 0.81-0.96) were inversely associated with hemorrhagic stroke. Associations were consistent across subgroups defined by age, race/ethnicity, blood pressure, hormone therapy use, BMI, and dietary intake. 
Conclusion: Increased recreational PA, particularly moderate, with cautious interpretation of vigorous activity due to its J-shaped association and potential risks, is associated with reduced risks of total and ischemic stroke in postmenopausal women. Our findings support promoting PA as a key strategy for stroke prevention in this population.
DOI: 10.6084/m9.figshare.30145894
title: Supplementary Material for: Effect of endobronchial valve treatment on skeletal muscles, fatigue, and sleep in severe emphysema patients

description: Introduction
Skeletal muscle dysfunction, fatigue, and poor sleep quality are common in severe emphysema patients. Endobronchial valve (EBV) treatment is a bronchoscopic procedure which improves pulmonary function, quality of life, and exercise capacity in these patients. However, its potential beneficial effects on skeletal muscle function, fatigue and sleep are unclear. Our aim was to investigate the effects of EBV treatment on these outcomes.

Methods
We conducted a prospective cohort study assessing the 2nd parasternal intercostal muscle thickening fraction, and quadriceps muscle thickness and rectus femoris cross-sectional area (RFCSA), both using ultrasound, limb muscle function using the 30-second sit-to-stand test, fatigue with the Checklist Individual Strength (CIS) fatigue subscale (score ≥36 indicating severe fatigue), and sleep quality with the Pittsburgh Sleep Quality Index (PSQI) at baseline and 6 months following EBV treatment.

Results
A total of twenty patients were included. At the six-month follow-up, significant improvements were observed in pulmonary function, quadriceps thickness and RFCSA in the nondominant leg, as well as in limb muscle function. Intercostal thickening fraction did not change following treatment. Fatigue decreased significantly, reducing severe fatigue prevalence from 70% to 25%. Sleep quality was generally poor and remained unchanged.

Conclusions
Our results show that quadriceps muscle size and function, as well as fatigue, significantly improve following EBV treatment in severe emphysema patients. However, BLVR seems to have no impact on intercostal thickening fraction and patient-reported sleep quality. This study highlights the beneficial extrapulmonary effects of EBV treatment in patients with severe emphysema, further supporting its clinical use.
DOI: 10.6084/m9.figshare.30145894.v1
title: Supplementary Material for: Effect of endobronchial valve treatment on skeletal muscles, fatigue, and sleep in severe emphysema patients

description: Introduction
Skeletal muscle dysfunction, fatigue, and poor sleep quality are common in severe emphysema patients. Endobronchial valve (EBV) treatment is a bronchoscopic procedure which improves pulmonary function, quality of life, and exercise capacity in these patients. However, its potential beneficial effects on skeletal muscle function, fatigue and sleep are unclear. Our aim was to investigate the effects of EBV treatment on these outcomes.

Methods
We conducted a prospective cohort study assessing the 2nd parasternal intercostal muscle thickening fraction, and quadriceps muscle thickness and rectus femoris cross-sectional area (RFCSA), both using ultrasound, limb muscle function using the 30-second sit-to-stand test, fatigue with the Checklist Individual Strength (CIS) fatigue subscale (score ≥36 indicating severe fatigue), and sleep quality with the Pittsburgh Sleep Quality Index (PSQI) at baseline and 6 months following EBV treatment.

Results
A total of twenty patients were included. At the six-month follow-up, significant improvements were observed in pulmonary function, quadriceps thickness and RFCSA in the nondominant leg, as well as in limb muscle function. Intercostal thickening fraction did not change following treatment. Fatigue decreased significantly, reducing severe fatigue prevalence from 70% to 25%. Sleep quality was generally poor and remained unchanged.

Conclusions
Our results show that quadriceps muscle size and function, as well as fatigue, significantly improve following EBV treatment in severe emphysema patients. However, BLVR seems to have no impact on intercostal thickening fraction and patient-reported sleep quality. This study highlights the beneficial extrapulmonary effects of EBV treatment in patients with severe emphysema, further supporting its clinical use.
DOI: 10.6084/m9.figshare.30145897
title: Supplementary Material for: Real world data: Survival outcomes and risk factors in extracorporeal membrane oxygenation use of cancer patient

description: Background/Purpose: Extracorporeal membrane oxygenation (ECMO) is a vital therapy for cardiopulmonary failure, yet its use in patients with cancer remains controversial due to immunosuppression and coagulopathy. Advances in oncology necessitate re-evaluating ECMO’s role in this population. This study investigates survival outcomes and prognostic factors in ECMO patients with and without cancer.
Methods: We analyzed a retrospective cohort of 342 adult ECMO patients treated at National Taiwan University Hospital Hsin-chu Branch between January 2017 to December 2023. Patient demographics, medical history, and pre-ECMO laboratory parameters were assessed. Kaplan–Meier curves and Cox proportional hazards models were used to identify survival predictors.
Results: Among the 342 patients, 40 had cancer, with solid tumors constituting 92.5% of cases. 90-day mortality were 56.8% for non-cancer patients and 70.0% for cancer patients, with no significant difference (p = 0.087). Hyperlactatemia (&gt;10 mmol/L, HR: 2.74, p &lt; 0.001) and hypoalbuminemia (&lt; 2.4 g/dL, HR: 1.76, p = 0.018) were significantly associated with worse survival outcomes in the multivariable analysis. Cancer status was not statistically significant (HR: 1.41, p = 0.114). Subgroup analyses in cancer patients confirmed elevated lactate (&gt;10 mmol/L, HR: 8.85, p &lt; 0.001) and low albumin (&lt; 3.4 g/dL, HR: 3.62, p = 0.018) as significant prognostic factors.
Conclusions: ECMO may be an option in highly selected patients with solid tumors and without significant metabolic derangements. Elevated lactate and low albumin predict poor outcomes, highlighting the need for early metabolic optimization. ECMO is a potential bridge therapy for critically ill cancer patients, warranting further validation and assessment of the impact of modern oncologic therapies on outcomes. Only three patients in this study had hematologic malignancies. Therefore, the findings primarily reflect outcomes in patients with solid tumors and should not be generalized to those with hematologic cancers.
DOI: 10.6084/m9.figshare.30145897.v1
title: Supplementary Material for: Real world data: Survival outcomes and risk factors in extracorporeal membrane oxygenation use of cancer patient

description: Background/Purpose: Extracorporeal membrane oxygenation (ECMO) is a vital therapy for cardiopulmonary failure, yet its use in patients with cancer remains controversial due to immunosuppression and coagulopathy. Advances in oncology necessitate re-evaluating ECMO’s role in this population. This study investigates survival outcomes and prognostic factors in ECMO patients with and without cancer.
Methods: We analyzed a retrospective cohort of 342 adult ECMO patients treated at National Taiwan University Hospital Hsin-chu Branch between January 2017 to December 2023. Patient demographics, medical history, and pre-ECMO laboratory parameters were assessed. Kaplan–Meier curves and Cox proportional hazards models were used to identify survival predictors.
Results: Among the 342 patients, 40 had cancer, with solid tumors constituting 92.5% of cases. 90-day mortality were 56.8% for non-cancer patients and 70.0% for cancer patients, with no significant difference (p = 0.087). Hyperlactatemia (&gt;10 mmol/L, HR: 2.74, p &lt; 0.001) and hypoalbuminemia (&lt; 2.4 g/dL, HR: 1.76, p = 0.018) were significantly associated with worse survival outcomes in the multivariable analysis. Cancer status was not statistically significant (HR: 1.41, p = 0.114). Subgroup analyses in cancer patients confirmed elevated lactate (&gt;10 mmol/L, HR: 8.85, p &lt; 0.001) and low albumin (&lt; 3.4 g/dL, HR: 3.62, p = 0.018) as significant prognostic factors.
Conclusions: ECMO may be an option in highly selected patients with solid tumors and without significant metabolic derangements. Elevated lactate and low albumin predict poor outcomes, highlighting the need for early metabolic optimization. ECMO is a potential bridge therapy for critically ill cancer patients, warranting further validation and assessment of the impact of modern oncologic therapies on outcomes. Only three patients in this study had hematologic malignancies. Therefore, the findings primarily reflect outcomes in patients with solid tumors and should not be generalized to those with hematologic cancers.
DOI: 10.15468/dl.f74awf
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Tanacetum balsamita",
 "Country is Cyprus",
 "HasCoordinate is true"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010050-250914085247600/datasets/export for details.
DOI: 10.6084/m9.figshare.30145900.v1
title: Supplementary Material for: Sex-specific Differences in Ultrasound-Derived Muscle Parameters and Their Associations with Strength and Physical Function in Older Adults: A Systematic Review and Meta-Analysis

description: Background: Ultrasound technology is a promising tool for assessing muscle condition in older adults. However, sex-specific differences in how ultrasound-derived muscle parameters related to the physical function remain unclear.

Methods: A systematic search of PubMed, Web of Science, Embase, CINAHL, and SPORTDiscus was conducted to identify studies reporting sex-stratified associations between ultrasound-derived muscle parameters and functional measures. Correlation coefficients were transformed using Fisher’s z-transformation and analyzed with random-effects models, then back-transformed to Pearson’s r. Heterogeneity was assessed using the I2 statistic, and publication bias was evaluated using funnel plots and Egger’s test.
Results: Analysis of 39 studies revealed that ultrasound-derived muscle parameters were consistently correlated with strength assessments across sexes, including maximal and handgrip strength (males: muscle thickness [MT], r = 0.30–0.42; echo intensity [EI], r = -0.34 to -0.38; females: MT, r = 0.34–0.37; EI, r = -0.34 to -0.35; all p &gt; 0.05). However, for explosive power, both MT and EI had stronger associations in males than females (MT: r = 0.70 vs. 0.42; EI: r = -0.52 vs. -0.27; both p &lt; 0.05). In gait function, MT was positively correlated in females (r = 0.22, p &lt; 0.05) but not in males (r = -0.03, p = 0.62). Additionally, EI correlations were significantly stronger in females than males in the Timed Up and Go (TUG) test (r = 0.40 vs. 0.19, p &lt; 0.05).
Conclusions: This meta-analysis revealed that MT and EI exhibit comparable correlations with maximal and handgrip strength across sexes. However, both parameters show stronger associations with explosive power in males. In contrast, females displayed more robust associations with physical function, with MT being more strongly linked to gait speed and EI to TUG performance. These findings highlight the need for sex-specific considerations in ultrasound-based muscle evaluations and provide foundational data to inform future clinical applications.
DOI: 10.6084/m9.figshare.30145900
title: Supplementary Material for: Sex-specific Differences in Ultrasound-Derived Muscle Parameters and Their Associations with Strength and Physical Function in Older Adults: A Systematic Review and Meta-Analysis

description: Background: Ultrasound technology is a promising tool for assessing muscle condition in older adults. However, sex-specific differences in how ultrasound-derived muscle parameters related to the physical function remain unclear.

Methods: A systematic search of PubMed, Web of Science, Embase, CINAHL, and SPORTDiscus was conducted to identify studies reporting sex-stratified associations between ultrasound-derived muscle parameters and functional measures. Correlation coefficients were transformed using Fisher’s z-transformation and analyzed with random-effects models, then back-transformed to Pearson’s r. Heterogeneity was assessed using the I2 statistic, and publication bias was evaluated using funnel plots and Egger’s test.
Results: Analysis of 39 studies revealed that ultrasound-derived muscle parameters were consistently correlated with strength assessments across sexes, including maximal and handgrip strength (males: muscle thickness [MT], r = 0.30–0.42; echo intensity [EI], r = -0.34 to -0.38; females: MT, r = 0.34–0.37; EI, r = -0.34 to -0.35; all p &gt; 0.05). However, for explosive power, both MT and EI had stronger associations in males than females (MT: r = 0.70 vs. 0.42; EI: r = -0.52 vs. -0.27; both p &lt; 0.05). In gait function, MT was positively correlated in females (r = 0.22, p &lt; 0.05) but not in males (r = -0.03, p = 0.62). Additionally, EI correlations were significantly stronger in females than males in the Timed Up and Go (TUG) test (r = 0.40 vs. 0.19, p &lt; 0.05).
Conclusions: This meta-analysis revealed that MT and EI exhibit comparable correlations with maximal and handgrip strength across sexes. However, both parameters show stronger associations with explosive power in males. In contrast, females displayed more robust associations with physical function, with MT being more strongly linked to gait speed and EI to TUG performance. These findings highlight the need for sex-specific considerations in ultrasound-based muscle evaluations and provide foundational data to inform future clinical applications.
DOI: 10.6084/m9.figshare.30145903
title: Supplementary Material for: Case report: Donor-derived clonal haematopoiesis after allogeneic stem cell transplantation

description: The accidental transmission of malignant and non-malignant hematological diseases through allogeneic hematopoietic cell transplantation has been described. Next-generation sequencing facilitates the detection of a wide range of mutations in suspected myeloid diseases. The transfer of clonal haematopoiesis is not uncommon and raises important medical and ethical considerations. We present two cases of donor-derived clonal haematopoiesis (CHIP) following allogeneic stem cell transplantation. In one case, the establishment of donor-derived CHIP was stabilized by donor-lymphocyte infusions given to counteract declining donor chimerism.
DOI: 10.6084/m9.figshare.30145903.v1
title: Supplementary Material for: Case report: Donor-derived clonal haematopoiesis after allogeneic stem cell transplantation

description: The accidental transmission of malignant and non-malignant hematological diseases through allogeneic hematopoietic cell transplantation has been described. Next-generation sequencing facilitates the detection of a wide range of mutations in suspected myeloid diseases. The transfer of clonal haematopoiesis is not uncommon and raises important medical and ethical considerations. We present two cases of donor-derived clonal haematopoiesis (CHIP) following allogeneic stem cell transplantation. In one case, the establishment of donor-derived CHIP was stabilized by donor-lymphocyte infusions given to counteract declining donor chimerism.